Culinary Art Cover Letter Sample

few thousand euros in millions.


I invest in stock market is a hoax, a scam devised by the bankers. "Give me your money I choose what suits you." The height of the scam have been the funds. Why Warren Buffet recommends small companies for the small investor? Because you can learn more. Because they have more potential. But above all, because he can choose! Investing in small companies with high growth potential has risks. But it has the advantage that a single winner can compensate for many losses. And finding a winner is a fascinating sport. The game is to transform a few thousand euros in millions in a period of 15 or 20 years. If you invest in 4 or 5 of those companies, no matter who fail two or three. The remaining offset these losses and ensure you a millionaire retirement. Of course the risk is not even a hit. That is what we must try to avoid. And in any case that is what would happen to the Investment Fund that was going to sell the bank, that would be correct not a single one. Worse will not do and you save the commissions. How to choose a company with growth potential? I'm going to contradict my friend The Braying , which owns shares in Pfizer. The time to invest in Pfizer was in 1985 . Not anymore. For many who discover miracle drugs, their growth is limited. The same is true of younger companies like Genentech. A careful investor would have invested in Genentech in 1990. But it is not the time to invest in Genentech, if we want to multiply our earnings over a hundred . The same is true of companies like Ford. Good time to invest in Ford was when they began to produce a luxury item, like cars, for the middle class. Model T. That had the capacity to grow. Now, with a market saturated with supply, in a mature industry, fighting for lower costs, and is not the time to invest in Ford. What then invest? That is the question whose answer differentiates a successful investor of another. This is not play the lottery and see if we succeed by chance. Can the hydrogen the replacement of oil? Do we invest in companies involved in that? Or renewable energy? Or in the mobile Internet? Or in biotechnology? We talked the other day RNAi . certainly one of my choices as a technology of the future is RNAi. What's yours? You can leave a message if you want to share which you think is the company or industry in the future. Do not fall for the scam bank to "invest in the stock market." It is good business to invest in good industries. Invest in good companies when they are taking, and taking advantage (or about to take advantage) to their best ideas! Investing in shares, not stock.

Culinary Art Cover Letter Sample

few thousand euros in millions.


I invest in stock market is a hoax, a scam devised by the bankers. "Give me your money I choose what suits you." The height of the scam have been the funds. Why Warren Buffet recommends small companies for the small investor? Because you can learn more. Because they have more potential. But above all, because he can choose! Investing in small companies with high growth potential has risks. But it has the advantage that a single winner can compensate for many losses. And finding a winner is a fascinating sport. The game is to transform a few thousand euros in millions in a period of 15 or 20 years. If you invest in 4 or 5 of those companies, no matter who fail two or three. The remaining offset these losses and ensure you a millionaire retirement. Of course the risk is not even a hit. That is what we must try to avoid. And in any case that is what would happen to the Investment Fund that was going to sell the bank, that would be correct not a single one. Worse will not do and you save the commissions. How to choose a company with growth potential? I'm going to contradict my friend The Braying , which owns shares in Pfizer. The time to invest in Pfizer was in 1985 . Not anymore. For many who discover miracle drugs, their growth is limited. The same is true of younger companies like Genentech. A careful investor would have invested in Genentech in 1990. But it is not the time to invest in Genentech, if we want to multiply our earnings over a hundred . The same is true of companies like Ford. Good time to invest in Ford was when they began to produce a luxury item, like cars, for the middle class. Model T. That had the capacity to grow. Now, with a market saturated with supply, in a mature industry, fighting for lower costs, and is not the time to invest in Ford. What then invest? That is the question whose answer differentiates a successful investor of another. This is not play the lottery and see if we succeed by chance. Can the hydrogen the replacement of oil? Do we invest in companies involved in that? Or renewable energy? Or in the mobile Internet? Or in biotechnology? We talked the other day RNAi . certainly one of my choices as a technology of the future is RNAi. What's yours? You can leave a message if you want to share which you think is the company or industry in the future. Do not fall for the scam bank to "invest in the stock market." It is good business to invest in good industries. Invest in good companies when they are taking, and taking advantage (or about to take advantage) to their best ideas! Investing in shares, not stock.

Core Skateboard Trucks

technology that can change the pharmaceutical industry: the RNA interference



traditional pharmaceutical industry is based on a simple principle: to discover the so-called "magic bullets" that can cure disease or relieve symptoms. For years it was a search industry by trial and error: a chemical is tested to see if it worked. If you did not work, try the following. Many of these compounds were artificial dyes, drugs or natural compounds and plant extracts. drugs were sought blindly. This paradigm quite primitive monopolized medicine until the invention of biotechnology, with the founding of the first company Biotechnology: Genentech. Investors in Genentech are rich today, multiplying your investment by 100 in 15 years , so that today would be 10mil euros one million euros. The idea of \u200b\u200bGenentech and other Biotechs early as Amgen, was to take human proteins, whose function was known, produced industrially and used as drugs. The patient was cured with substances that were not artificial, and dyes, or exogenous, such as plant extracts, but with substances produced by the human body and in which the patient was deficient. The first medicines were based on growth hormone, insulin or interferon, and antibodies to other proteins. It had the advantage that would not be so blindly. why biotechnology has saved many lives and become billionaires many investors. But biotechnology has a limitation: only proteins could act outside of cells, primarily in the bloodstream. entry and manipulation within the cells was forbidden territory. But the Nobel Prize for medicine this year honors the discovery that may forever change the treatment of disease. After many years, there is finally something to get excited about back in business pharmacist: RNA interference or RNAi. Two companies are the most important patents for this process: Sirna Therapeutics and Alnylam Pharmaceuticals . Both have increased their price by four in the last two or three years. And big companies have realized they are at risk of being left out of a total revolution that potentially encompasses the best of both worlds: able to develop as drugs, without going blind, as in classical biotechnology, but also access all corners of the human body, not just the blood, as in the pharmacy of the classic "magic bullets." Merck has been the first to react. Just make an offer for Sirna Therapeutics for more than one billion dollars. If there is a bidding war by siRNA, Merck opar one of the companies. Alnylam is only , which for many is even better company than siRNA. How may pay by Alnylam? Think it's scary, but the scariest thought may be worth as Alnylam if not sold and becomes the new Genentech of Biotechs 2.0 ... Alnylam Could be the Google of the pharmacy, the absolute ruler?

Disclosure: I have had shares of both companies in the past and still hold shares of Alnylam, as mentioned in a previous post.